Showing results (931-940 of 4,366) with videos related to

Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|September 1, 2018
Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1Zev Sthoeger, Amir Sharabi, Heidy Zinger, et al.
Clinical Immunology (Orlando, Fla.)|September 13, 2016
The magnitude of cytokine production by stimulated CD56+ cells is associated with early stages of systemic sclerosisMarta Cossu, Lenny van Bon, Stefan Nierkens, et al.
Clinical Immunology (Orlando, Fla.)|September 14, 2016
Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseasesZejun Zhou, Miao Ding, Lei Huang, et al.
Clinical Immunology (Orlando, Fla.)|February 20, 2010
Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetesPilar Londono, Akiko Komura, Naoko Hara, et al.
Clinical Immunology (Orlando, Fla.)|February 20, 2010
Immunoglobulin class switch recombination deficienciesS Kracker, P Gardes, F Mazerolles, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2016
An emerging role for eotaxins in neurodegenerative diseaseAmanda K Huber, David A Giles, Benjamin M Segal, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2016
Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiencyReza Yazdani, Mazdak Ganjalikhani-Hakemi, Mohammad Esmaeili, et al.
Clinical Immunology (Orlando, Fla.)|May 3, 2017
Influence of drug molecules on regulatory B cellsKahina Amrouche, Christophe Jamin
Clinical Immunology (Orlando, Fla.)|June 5, 2017
Multimarker risk stratification approach at multiple sclerosis onsetLidia Fernández-Paredes, Armanda Casrouge, Jérémie Decalf, et al.
Pageof 437